Caplin Point Labs gets USFDA nod for anticoagulant injection

Argatroban is used as an anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia, it added.Shares of Caplin Point Laboratories were trading at Rs 481.05 per scrip on BSE, down 0.97 per cent from its previous close.

PTI | New Delhi | Updated: 22-01-2021 14:28 IST | Created: 22-01-2021 14:02 IST
Caplin Point Labs gets USFDA nod for anticoagulant injection
Representative image Image Credit: Pixabay

Drug firm Caplin Point Laboratories on Friday said its arm Caplin Steriles has received final nod from the US health regulator for its generic anticoagulant Argatroban injection.

Caplin Steriles has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application for Argatroban injection, 50 mg/50 ml (1 mg/ml), single-dose vial presentation, it said in a filing to BSE.

The product is a generic version of Hikma Pharmaceuticals'Argatroban injection, it added.

Caplin has received a competitive generic therapy (CGT) grant for this abbreviated new drug application (ANDA) and is eligible for 180 days of CGT exclusivity for the product, the filing said.

''We're excited to receive our first approval with CGT exclusivity from our pipeline. We will target launching the product within the shortest time possible,'' Caplin Point Laboratories Chairman C C Paarthipan said.

According to IQVIA, Argatroban injection had US sales data of approximately USD 18 million for the 12-month period ended September 2020, the filing said. ''Argatroban is used as an anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia,'' it added.

Shares of Caplin Point Laboratories were trading at Rs 481.05 per scrip on BSE, down 0.97 per cent from its previous close.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Addressing conflict-related sexual violence at long last

... ...

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

KoineArth raises USD 1.8 mn funding from YourNest, others

Blockchain-based supply chain start-up KoineArth on Friday said it has raised USD 1.8 million over Rs 13 crore in funding led by YourNest Venture Capital.Existing investor, Inventus India, also participated in the round along with Lumis Par...

EU says pandemic disproportionately affects women, especially in frontline jobs

By Gabriela Baczynska BRUSSELS, March 5 ReutersM - Women in European Union countries have been disproportionately affected by the coronavirus pandemic because they make up the vast majority of workers in health and other frontline jobs, an ...

Singaporean Chinese jailed for possessing knife

A Chinese-origin Singaporean, originally accused of murdering an Indian-origin man following a brawl at a nightclub, was sentenced on Friday for up to five years after pleading guilty to a reduced charge of being in the company of someone w...

Sterling weakens against resurgent dollar

The British pound lost ground against a resurgent dollar on Friday, as currency traders took some risk off the table amid rising U.S. bond yields.U.S. Federal Reserve Chair Jerome Powell failed to soothe investor concerns about a recent sur...

Give Feedback